NCT00377923View on ClinicalTrials.gov

Endometrial Effects of Daily Progesterone s.c. 25 and 50 Mg Aqueous Formulation to Female Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2005

Study Completion Date

March 31, 2006

Conditions
Healthy
Interventions
DRUG

Progesterone

Sponsors
All Listed Sponsors
lead

IBSA Institut Biochimique SA

INDUSTRY

NCT00377923 - Endometrial Effects of Daily Progesterone s.c. 25 and 50 Mg Aqueous Formulation to Female Healthy Volunteers | Biotech Hunter | Biotech Hunter